Yongqing Li

Yongqing Li, MD, PhD

Assistant Professor of Surgery
Countries of Interest: China

Much of Dr. Li’s research, including his ongoing collaborations through the Michigan Medicine-Peking University Health Science Center Joint Institute, is focused on the treatment of sepsis with emphasis on histone modifying enzymes, including histone deacetylase (HDAC) and peptidylargine deiminase (PAD), as targets for therapeutics of trauma and sepsis.